Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion.
ORIGINAL SOURCE →via CNBC Top News
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · IN
- [NATURAL] Rain, storms to bring Delhi respite from heatwave soon. Here's what IMD said
- [CONFLICT] Indian rupee starts Monday at 94.23 per US dollar - NewsBytes
- [CONFLICT] India's 10-year yield hits 6.97% after government raised ₹32,000 cr - NewsBytes
- [CONFLICT] ‘Hope of getting justice broken’: Kejriwal writes to Delhi HC Justice Sharma, refuses to appear in court
- [CONFLICT] Gold price in India: Rates on April 27 - FXStreet
- [CONFLICT] Sun Pharma to acquire US-based Organon in $11.75 billion deal, among biggest overseas buys by Indian firm - The Times of India